PL124515B1 - Process for preparing novel complex compounds of 6-substituted 9-/hydroxyalkyl/purines - Google Patents
Process for preparing novel complex compounds of 6-substituted 9-/hydroxyalkyl/purines Download PDFInfo
- Publication number
- PL124515B1 PL124515B1 PL1979226683A PL22668379A PL124515B1 PL 124515 B1 PL124515 B1 PL 124515B1 PL 1979226683 A PL1979226683 A PL 1979226683A PL 22668379 A PL22668379 A PL 22668379A PL 124515 B1 PL124515 B1 PL 124515B1
- Authority
- PL
- Poland
- Prior art keywords
- compounds
- npt
- cells
- compound
- activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/36—Sulfur atom
- C07D473/38—Sulfur atom attached in position 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/942,802 US4221909A (en) | 1978-09-15 | 1978-09-15 | P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL124515B1 true PL124515B1 (en) | 1983-01-31 |
Family
ID=25478620
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1979226683A PL124515B1 (en) | 1978-09-15 | 1979-09-14 | Process for preparing novel complex compounds of 6-substituted 9-/hydroxyalkyl/purines |
| PL1979218317A PL119685B1 (en) | 1978-09-15 | 1979-09-14 | Process for preparing novel complex compounds of 6-substituted 9-/hydroxyalkyl/-purinesehhennykh 9-/gidroksialkil/-purinov |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1979218317A PL119685B1 (en) | 1978-09-15 | 1979-09-14 | Process for preparing novel complex compounds of 6-substituted 9-/hydroxyalkyl/-purinesehhennykh 9-/gidroksialkil/-purinov |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4221909A (enExample) |
| EP (1) | EP0009154B1 (enExample) |
| JP (1) | JPS5547683A (enExample) |
| KR (1) | KR840000552A (enExample) |
| AT (1) | ATE1949T1 (enExample) |
| AU (1) | AU527851B2 (enExample) |
| CA (1) | CA1122217A (enExample) |
| CS (1) | CS251060B2 (enExample) |
| DD (1) | DD146049A5 (enExample) |
| DE (1) | DE2964211D1 (enExample) |
| DK (1) | DK149857C (enExample) |
| ES (1) | ES484167A1 (enExample) |
| FI (1) | FI68234C (enExample) |
| GR (1) | GR74076B (enExample) |
| HU (1) | HU182544B (enExample) |
| IE (1) | IE48827B1 (enExample) |
| IL (1) | IL58087A (enExample) |
| IN (1) | IN153099B (enExample) |
| MX (1) | MX6521E (enExample) |
| NO (1) | NO152445C (enExample) |
| NZ (1) | NZ191483A (enExample) |
| PH (1) | PH16315A (enExample) |
| PL (2) | PL124515B1 (enExample) |
| PT (1) | PT70180A (enExample) |
| RO (1) | RO77565A (enExample) |
| YU (1) | YU41884B (enExample) |
| ZA (1) | ZA793973B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4340726A (en) * | 1980-03-14 | 1982-07-20 | Newport Pharmaceuticals International, Inc. | Esters |
| US4451478A (en) * | 1982-03-12 | 1984-05-29 | Newport Pharmaceuticals International, Inc. | Imidazole compounds |
| US4849411A (en) * | 1982-11-09 | 1989-07-18 | Scripps Clinic And Research Foundation | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives |
| US5147636A (en) * | 1982-11-09 | 1992-09-15 | Scripps Clinic And Research Foundation | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives and interferons |
| HUT36464A (en) * | 1983-05-24 | 1985-09-30 | Newport Pharmaceuticals | Process for producing erythro-4-amino-3-/2-hydroxy-3-alkyl/-imidazol-5-carboxamide |
| IT1215339B (it) * | 1987-01-14 | 1990-02-08 | Co Pharma Corp Srl | Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine |
| US5091432A (en) * | 1990-03-28 | 1992-02-25 | Glasky Alvin J | 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use |
| US5614504A (en) * | 1990-08-01 | 1997-03-25 | The University Of South Florida | Method of making inosine monophosphate derivatives and immunopotentiating uses thereof |
| US6338963B1 (en) | 1994-07-25 | 2002-01-15 | Neotherapeutics, Inc. | Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| PL318293A1 (en) | 1994-07-25 | 1997-06-09 | Alvin J Glasky | Carbon monoxide dependent guanilyl cyclase modifiers |
| WO1997028803A1 (en) * | 1996-02-12 | 1997-08-14 | Cypros Pharmaceutical Corporation | Hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemic traits |
| US6303617B1 (en) | 1998-05-04 | 2001-10-16 | Neotherapeutics, Inc. | Serotonin-like 9-substituted hypoxanthine and methods of use |
| US6297226B1 (en) | 1999-10-15 | 2001-10-02 | Neotherapeutics, Inc. | Synthesis and methods of use of 9-substituted guanine derivatives |
| US6288069B1 (en) | 1999-11-16 | 2001-09-11 | Neotherapeutics, Inc. | Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| US6407237B1 (en) | 2001-02-21 | 2002-06-18 | Neotherapeutics, Inc. | Crystal forms of 9-substituted hypoxanthine derivatives |
| US6849735B1 (en) * | 2000-06-23 | 2005-02-01 | Merck Eprova Ag | Methods of synthesis for 9-substituted hypoxanthine derivatives |
| US6630490B2 (en) | 2000-07-07 | 2003-10-07 | Neotherapeutics, Inc. | Methods for treatment of disease-induced peripheral neuropathy and related conditions |
| US6759427B2 (en) * | 2001-04-20 | 2004-07-06 | Spectrum Pharmaceuticals, Inc. | Synthesis and methods of use of tetrahydroindolone analogues and derivatives |
| US20030055249A1 (en) * | 2001-07-17 | 2003-03-20 | Fick David B. | Synthesis and methods of use of pyrimidine analogues and derivatives |
| AR046172A1 (es) * | 2003-10-03 | 2005-11-30 | 3M Innovative Properties Co | Pirazolopiridinas y sus analogos; composiciones farmaceuticas que los contienen y su uso en la inhibicion de la biosintesis de citocinas |
| WO2005074946A1 (en) * | 2004-02-10 | 2005-08-18 | Adenobio N.V. | Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases |
| USD529397S1 (en) | 2004-08-18 | 2006-10-03 | Gabrielle Studio, Inc. | Cosmetic container |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3215696A (en) * | 1965-11-02 | Substituted adenines -and preparation thereof | ||
| US3728450A (en) * | 1969-08-28 | 1973-04-17 | Newport Pharmaceuticals | Inosine derivatives |
| BE755361A (fr) * | 1969-08-28 | 1971-03-01 | Newport Pharmaceuticals | Derives de l'inosine |
| US3857940A (en) * | 1971-05-21 | 1974-12-31 | Newport Pharmaceuticals | Inosine derivatives |
| US3836656A (en) * | 1972-02-07 | 1974-09-17 | Sandoz Ag | Substituted purines as hypolipidemics |
| US3862189A (en) * | 1973-08-14 | 1975-01-21 | Warner Lambert Co | Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents |
| US4060616A (en) * | 1976-03-01 | 1977-11-29 | Burroughs Wellcome Co. | Purine derivatives with repeating unit |
| YU96177A (en) * | 1976-04-24 | 1982-08-31 | Wuelfing Johann A | Process for obtaining adenine derivatives |
-
1978
- 1978-09-15 US US05/942,802 patent/US4221909A/en not_active Expired - Lifetime
-
1979
- 1979-08-02 ZA ZA00793973A patent/ZA793973B/xx unknown
- 1979-08-22 IL IL58087A patent/IL58087A/xx unknown
- 1979-08-28 NO NO792792A patent/NO152445C/no unknown
- 1979-08-31 IN IN618/DEL/79A patent/IN153099B/en unknown
- 1979-08-31 DE DE7979103232T patent/DE2964211D1/de not_active Expired
- 1979-08-31 EP EP79103232A patent/EP0009154B1/en not_active Expired
- 1979-08-31 AT AT79103232T patent/ATE1949T1/de not_active IP Right Cessation
- 1979-09-04 AU AU50557/79A patent/AU527851B2/en not_active Ceased
- 1979-09-05 NZ NZ191483A patent/NZ191483A/xx unknown
- 1979-09-07 PH PH23010A patent/PH16315A/en unknown
- 1979-09-12 DD DD79215495A patent/DD146049A5/de not_active IP Right Cessation
- 1979-09-13 GR GR60030A patent/GR74076B/el unknown
- 1979-09-13 FI FI792849A patent/FI68234C/fi not_active IP Right Cessation
- 1979-09-14 IE IE1753/79A patent/IE48827B1/en not_active IP Right Cessation
- 1979-09-14 PL PL1979226683A patent/PL124515B1/pl unknown
- 1979-09-14 PL PL1979218317A patent/PL119685B1/pl unknown
- 1979-09-14 CS CS796226A patent/CS251060B2/cs unknown
- 1979-09-14 ES ES484167A patent/ES484167A1/es not_active Expired
- 1979-09-14 HU HU79NE619A patent/HU182544B/hu not_active IP Right Cessation
- 1979-09-14 PT PT70180A patent/PT70180A/pt unknown
- 1979-09-14 YU YU2245/79A patent/YU41884B/xx unknown
- 1979-09-14 DK DK385679A patent/DK149857C/da not_active IP Right Cessation
- 1979-09-14 CA CA000335702A patent/CA1122217A/en not_active Expired
- 1979-09-14 JP JP11743979A patent/JPS5547683A/ja active Granted
- 1979-09-15 KR KR1019790003209A patent/KR840000552A/ko not_active Ceased
- 1979-09-17 MX MX798386U patent/MX6521E/es unknown
- 1979-11-14 RO RO7998665A patent/RO77565A/ro unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL119685B1 (en) | Process for preparing novel complex compounds of 6-substituted 9-/hydroxyalkyl/-purinesehhennykh 9-/gidroksialkil/-purinov | |
| FI67847C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 9-hydroxialkylpuriner | |
| US4221794A (en) | Method of imparting immunomodulating and antiviral activity | |
| EP1142893B1 (en) | Substituted 6(4)-benzyloxypyrimidines | |
| SU843746A3 (ru) | Способ получени аминотиазоловили иХ КиСлОТНО-АддиТиВНыХ СОлЕй | |
| US4287188A (en) | Purine derivatives | |
| CS203092B2 (en) | Method of preparing substituted purines | |
| SK161095A3 (en) | Chemical compounds having pde-iv inhibition activity | |
| PL148689B1 (en) | Method of obtaining novel carbocyclic nucleosides | |
| CZ20022353A3 (cs) | Deriváty purinu, způsob jejich přípravy a jejich použití | |
| GB2175903A (en) | Anti-cancer quinazolines | |
| US6200974B1 (en) | Phenanthroline derivatives | |
| AU754607B2 (en) | Phenanthroline derivatives | |
| El-Tombary et al. | Novel triazolo [4, 3-a] quinazolinone and bis-triazolo [4, 3-a: 4, 3′-c] quinazolines: synthesis and antitoxoplasmosis effect | |
| CZ2009298A3 (cs) | Substituované 6-benzylaminopurin ribosidy, jejich použití a farmaceutický prípravek tyto slouceniny obsahující | |
| AU597770B2 (en) | Pyrimidine derivatives | |
| Gao et al. | Conjugation of weak ligands with weak antigens to activate TLR-7: A step toward better vaccine adjuvants | |
| CN119350305B (zh) | eEF2K抑制剂及其制备和在制备抗肿瘤药物中的应用 | |
| AU646452B2 (en) | O6-benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing O6-alkylguanine-DNA alkyltransferase depleting activity | |
| JPH02247191A (ja) | 抗レトロウイルス剤としてのプリンおよびピリミジン非環状ヌクレオシドの環状モノホスフエート類 | |
| CA1224464A (en) | Purine dihydrothiazole | |
| NZ199643A (en) | Treatment with immunomodulators and antiviral agents which are 9-(2-hydroxyalkyl) purine amine salt complexes | |
| CZ278709B6 (en) | Process for preparing condensed pyrimidine derivatives | |
| CN110655534A (zh) | 替诺福韦脂质单酯化合物及其制备方法和应用 | |
| Maag | Case Study: Valganciclovir: A Prodrug of Ganciclovir |